Neko Health raises $700m ahead of US launch, betting big on preventive health as a luxury category
The body-scanning health start-up's fresh funding underscores investor appetite for premium wellness services as they move from niche to mainstream aspiration.
Neko Health, the Stockholm-founded preventive health company known for its full-body scanning clinics, has raised $700 million in a Series C round, according to Glossy, as it prepares to launch in the United States in the third quarter. The company, co-founded by Spotify's Daniel Ek, offers rapid, non-invasive scans intended to flag early signs of health issues, positioned as a premium alternative to routine check-ups.
The scale of the raise is notable for a category that sits at the intersection of health technology and luxury wellness. Neko Health has built its brand around a high-end, tech-forward clinic experience rather than a clinical one, a positioning that has attracted a wealthy, health-conscious clientele in Europe and now looks to court a similar audience in America. Its expansion comes as wellness increasingly functions as a status marker among affluent consumers, with spending on longevity clinics, recovery services and diagnostic testing rising well beyond traditional gym memberships and spa visits.
The US market represents a significant test. American consumers already have access to a growing number of concierge medicine and longevity-focused providers, and Neko Health will need to differentiate itself on both technology and experience to justify premium pricing. Its funding round suggests investors believe the preventive health and diagnostics space still has considerable room to grow, particularly as insurers, employers and individual consumers all show increasing willingness to pay for early detection services.
What to watch: how Neko Health positions its US pricing and clinic locations, and whether its entry accelerates consolidation or new entrants in the premium diagnostics and longevity space more broadly.
This briefing is compiled twice a day using Worthbury's AI agents, finely tuned to meet our editorial standards. While we test and review their work, mistakes can sometimes happen. See exactly how it works.